The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
Open accessAbstract
Mice lacking natriuretic peptide receptor A (NPRA) have marked cardiac hypertrophy and chamber dilatation disproportionate to their increased blood pressure (BP), suggesting, in support of previous in vitro data, that the NPRA system moderates the cardiac response to hypertrophic stimuli. Here, we have followed the changes in cardiac function in response to altered mechanical load on the heart of NPRA-null mice (Npr1-/-). Chronic treatment with either enalapril, furosemide, hydralazine, or losartan were all effective in reducing and maintaining BP at normal levels without affecting heart weight/body weight. In the reverse direction, we used transverse aortic constriction (TAC) to induce pressure overload. In the Npr1-/- mice, TAC resulted in a 15-fold increase in atrial natriuretic peptide (ANP) expression, a 55% increase in left ventricular weight/body weight (LV/BW), dilatation of the LV, and significant decline in cardiac function. In contrast, banded Npr1+/+ mice showed only a threefold increase in ANP expression, an 11% increase in LV/BW, a 0.2 mm decrease in LV end diastolic dimension, and no change in fractional shortening. The activation of mitogen-activated protein kinases that occurs in response to TAC did not differ in the Npr1+/+ and Npr1-/- mice. Taken together, these results suggest that the NPRA system has direct antihypertrophic actions in the heart, independent of its role in BP control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 797
Self-citationRetractedEpstein, F. H., Levin, E. R., Gardner, D. G., & Samson, W. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390507 · Cited by 1,927
Hormones and Hemodynamics in Heart Failure
Schrier, R. W., & Abraham, W. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410806 · Cited by 1,199
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
Shesely, E. G., Maeda, N., Kim, H.-S., Desai, K. M., Krege, J. H., Laubach, V. E., Sherman, P. A., Sessa, W. C., & Smithies, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13176 · Cited by 914
Self-citationSignaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
Wang, Y., Huang, S., Sah, V. P., Ross, J., Brown, J. H., Han, J., & Chien, K. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2161 · Cited by 842
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive Hypertension
John, S. W. M., Krege, J. H., Oliver, P. M., Hagaman, J. R., Hodgin, J. B., Pang, S. C., Flynn, T. G., & Smithies, O. (1995) · Science · doi:10.1126/science.7839143 · Cited by 645
Self-citationCardiac fibrosis in mice lacking brain natriuretic peptide
Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M., Kasahara, M., Hashimoto, R., Katsuura, G., Mukoyama, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070371497 · Cited by 620
Sadoshima, J., Jahn, L., Takahashi, T., Kulik, T. J., & Izumo, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50052-7 · Cited by 605
A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice
Krege, J. H., Hodgin, J. B., Hagaman, J. R., & Smithies, O. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1111 · Cited by 587
Self-citationHypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
Oliver, P. M., Fox, J. E., Kim, R., Rockman, H. A., Kim, H.-S., Reddick, R. L., Pandey, K. N., Milgram, S. L., Smithies, O., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14730 · Cited by 576
Self-citationCalderone, A., Thaik, C. M., Takahashi, N., Chang, D. L., & Colucci, W. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119883 · Cited by 490
Lopez, M. J., Wong, S. K.-F., Kishimoto, I., Dubois, S., Mach, V., Friesen, J., Garbers, D. L., & Beuve, A. (1995) · Nature · doi:10.1038/378065a0 · Cited by 483
Greenberg, B., Quinones, M. A., Koilpillai, C., Limacher, M., Shindler, D., Benedict, C., & Shelton, B. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
Lessons from rat models of hypertension from Goldblatt to genetic engineering
Pinto, Y. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00077-7 · Cited by 340
Wang, Y., Su, B., Sah, V. P., Brown, J. H., Han, J., & Chien, K. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5423 · Cited by 339
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Itoh, H., Pratt, R. E., & Dzau, V. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114893 · Cited by 326
Brilla, C. G., Janicki, J. S., & Weber, K. T. (1991) · Circulation · doi:10.1161/01.cir.83.5.1771 · Cited by 325
Gottdiener, J. S., Reda, D. J., Massie, B. M., Materson, B. J., Williams, D. W., & Anderson, R. J. (1997) · Circulation · doi:10.1161/01.cir.95.8.2007 · Cited by 284
Mosterd, A., D'Agostino, R. B., Silbershatz, H., Sytkowski, P. A., Kannel, W. B., Grobbee, D. E., & Levy, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401601 · Cited by 283
Pfeffer, J. M., Pfeffer, M. A., Mirsky, I., & Braunwald, E. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3310 · Cited by 264
Cardiac hypertrophy and antihypertensive therapy
SEN, S., TARAZI, R. C., & BUMPUS, F. M. (1977) · Cardiovascular Research · doi:10.1093/cvr/11.5.427 · Cited by 257
Horio, T., Nishikimi, T., Yoshihara, F., Matsuo, H., Takishita, S., & Kangawa, K. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.19 · Cited by 238
Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.
Saito, Y., Nakao, K., Arai, H., Nishimura, K., Okumura, K., Obata, K., Takemura, G., Fujiwara, H., Sugawara, A., & Yamada, T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113872 · Cited by 237
Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes
Wu, C.-F., Bishopric, N. H., & Pratt, R. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14860 · Cited by 235
Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
Hasegawa, K., Fujiwara, H., Doyama, K., Miyamae, M., Fujiwara, T., Suga, S., Mukoyama, M., Nakao, K., Imura, H., & Sasayama, S. (1993) · Circulation · doi:10.1161/01.cir.88.2.372 · Cited by 213
Glennon, P. E., Kaddoura, S., Sale, E. M., Sale, G. J., Fuller, S. J., & Sugden, P. H. (1996) · Circulation Research · doi:10.1161/01.res.78.6.954 · Cited by 206
Gottdiener, J. S., Reda, D. J., Williams, D. W., Materson, B. J., Cushman, W., & Anderson, R. J. (1998) · Circulation · doi:10.1161/01.cir.98.2.140 · Cited by 203
Friddle, C. J., Koga, T., Rubin, E. M., & Bristow, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127897 · Cited by 201
Choukroun, G., Hajjar, R., Fry, S., del Monte, F., Haq, S., Guerrero, J. L., Picard, M., Rosenzweig, A., & Force, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6350 · Cited by 174
Rockman, H. A., Wachhorst, S. P., Mao, L., & Ross, J. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2468 · Cited by 160
Self-citationABC of heart failure: Pathophysiology
Jackson, G. S. (2000) · BMJ · doi:10.1136/bmj.320.7228.167 · Cited by 149
Role of atrial natriuretic factor in volume control
Maack, T. (1996) · Kidney International · doi:10.1038/ki.1996.257 · Cited by 142
Esposito, G., Prasad, S. V. N., Rapacciuolo, A., Mao, L., Koch, W. J., & Rockman, H. A. (2001) · Circulation · doi:10.1161/01.cir.103.10.1453 · Cited by 135
Self-citationPhysiology of natriuretic peptides
Espiner, E. A. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01261.x · Cited by 135
Nakayama, T., Soma, M., Takahashi, Y., Rehemudula, D., Kanmatsuse, K., & Furuya, K. (2000) · Circulation Research · doi:10.1161/01.res.86.8.841 · Cited by 132
Davies, M. K., Gibbs, C. R., & Lip, G. Y. H. (2000) · PubMed Central · doi:10.1136/bmj.320.7230.297 · Cited by 132
Cellular and functional defects in a mouse model of heart failure
Esposito, G., Santana, L. F., Dilly, K. W., Cruz, J. S., Mao, L., Lederer, W. J., & Rockman, H. A. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.6.h3101 · Cited by 120
Self-citationMechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells
Hutchinson, H. G., Trindade, P. T., Cunanan, D. B., Wu, C. F., & Pratt, R. E. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00086-2 · Cited by 100
Silberbach, M., Gorenc, T., Hershberger, R. E., Stork, P. A., Steyger, P. S., & Roberts, C. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24858 · Cited by 97
Thorburn, G. D., & Harding, R. (1994) · Oxford University Press eBooks · Cited by 96
Knowlton, K. U., Rockman, H. A., Itani, M., Vovan, A., Seidman, C. E., & Chien, K. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118166 · Cited by 95
Self-citationEnalapril and Losartan Reduced Cardiac Mass and Improved Coronary Hemodynamics in SHR
Núñez, E., Hosoya, K., Sušić, D., & Frohlich, E. D. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.519 · Cited by 86
Clinical Misconceptions Dispelled by Epidemiological Research
Kannel, W. B. (1995) · Circulation · doi:10.1161/01.cir.92.11.3350 · Cited by 85
Apoptosis During Regression of Cardiac Hypertrophy in Spontaneously Hypertensive Rats
Tea, B.-S., Dam, T.-V., Moreau, P. R., Hamet, P., & deBlois, D. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.229 · Cited by 69
Angiotensin II Increases Left Ventricular Mass Without Affecting Myosin Isoform mRNAs
Sušić, D., Núñez, E., Frohlich, E. D., & Prakash, O. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.265 · Cited by 57
Dubois, S. K., Kishimoto, I., Lillis, T. O., & Garbers, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4369 · Cited by 37
Cardiac hypertrophy: Old concepts, new perspectives
Gupta, M., & Gupta, M. P. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5765-4_35 · Cited by 15
Cardiac hypertrophy: Old concepts, new perspectives
Gupta, M., & Gupta, M. P. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006865515646 · Cited by 10
Cited by
Potter, L. R., Abbey-Hosch, S., & Dickey, D. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0014 · Cited by 1,002
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
Fan, D., Takawale, A., Lee, J., & Kassiri, Z. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-15 · Cited by 814
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 770
Potter, L. R., Yoder, A. R., Flora, D. R., Antos, L. K., & Dickey, D. M. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68964-5_15 · Cited by 647
Metadata
- Authors
- Knowles, J. W., Esposito, G., Mao, L., Hagaman, J. R., Fox, J. E., Smithies, O., Rockman, H. A., & Maeda, N.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-04-15
- Volume
- 107
- Issue
- 8
- Pages
- 975-984
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2030165232
- Cited by
- 302
- References
- 50
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.